These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34360986)

  • 61. Late Development of FcεRγ
    Muccio L; Falco M; Bertaina A; Locatelli F; Frassoni F; Sivori S; Moretta L; Moretta A; Della Chiesa M
    Front Immunol; 2018; 9():1050. PubMed ID: 29868012
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Dendritic cell vaccination in an allogeneic stem cell recipient receiving a transplant from a human cytomegalovirus (HCMV)-seronegative donor: induction of a HCMV-specific T(helper) cell response.
    Feuchtinger T; Opherk K; Bicanic O; Schumm M; Grigoleit GU; Hamprecht K; Jahn G; Handgretinger R; Lang P
    Cytotherapy; 2010 Nov; 12(7):945-50. PubMed ID: 20230226
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Increased human cytomegalovirus (HCMV) DNA load in peripheral blood leukocytes after lung transplantation correlates with HCMV pneumonitis.
    Michaelides A; Liolios L; Glare EM; Spelman DW; Bailey MJ; Walters EH; Williams TJ; Snell GI; Kotsimbos TC
    Transplantation; 2001 Jul; 72(1):141-7. PubMed ID: 11468549
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Predictive value of human cytomegalovirus (HCMV) T-cell response in the control of HCMV infection by seropositive solid-organ transplant recipients according to different assays and stimuli.
    Gabanti E; Bruno F; Scaramuzzi L; Mangione F; Zelini P; Gerna G; Lilleri D
    New Microbiol; 2016 Oct; 39(4):247-258. PubMed ID: 27727404
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Monoclonal Antibodies Specific for the V2, V3, CD4-Binding Site, and gp41 of HIV-1 Mediate Phagocytosis in a Dose-Dependent Manner.
    Musich T; Li L; Liu L; Zolla-Pazner S; Robert-Guroff M; Gorny MK
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28122974
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CD8+ T cell responses in children with congenital or postnatal human cytomegalovirus infection.
    Gibson L; Piccinini G; Lilleri D; Revello MG; Wang Z; Markel S; Diamond DJ; Luzuriaga K
    J Immunol; 2004 Feb; 172(4):2256-64. PubMed ID: 14764694
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Molecular fine-specificity analysis of antibody responses to human cytomegalovirus and design of novel synthetic-peptide-based serodiagnostic assays.
    Greijer AE; van de Crommert JM; Stevens SJ; Middeldorp JM
    J Clin Microbiol; 1999 Jan; 37(1):179-88. PubMed ID: 9854087
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Late diversification in the clonal composition of human cytomegalovirus-specific CD8+ T cells following allogeneic hemopoietic stem cell transplantation.
    Gandhi MK; Wills MR; Okecha G; Day EK; Hicks R; Marcus RE; Sissons JG; Carmichael AJ
    Blood; 2003 Nov; 102(9):3427-38. PubMed ID: 12869514
    [TBL] [Abstract][Full Text] [Related]  

  • 69. CD45RA expression on HCMV-specific effector memory CD8+ T cells is associated with the duration and intensity of HCMV replication after transplantation.
    Cantisán S; Solana R; Lara R; Rodríguez-Benot A; Vaquero JM; Gutiérrez-Aroca J; Gayoso I; Montejo M; Rivero A; Torre-Cisneros J
    Clin Immunol; 2010 Oct; 137(1):81-8. PubMed ID: 20674505
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Human cytomegalovirus specific CD8(+) T lymphocytes display interferon-gamma secretion impairment in kidney transplant recipients with pp65 antigenemia.
    Yang R; Xia T; Xu G; Li Z; Ying Z; Xu X
    Transplant Proc; 2008 Dec; 40(10):3500-4. PubMed ID: 19100424
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Human cytomegalovirus load in the peripheral blood determined by quantitative competitive polymerase chain reaction.
    Szöke K; Szládek G; Szarka K; Juhász A; Veress G; Gergely L; Kónya J
    Acta Microbiol Immunol Hung; 2001; 48(3-4):313-21. PubMed ID: 11791336
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Human cytomegalovirus end-organ disease is associated with high or low systemic viral load in preemptively treated solid-organ transplant recipients.
    Gerna G; Lilleri D; Furione M; Castiglioni B; Meloni F; Rampino T; Agozzino M; Arbustini E
    New Microbiol; 2012 Jul; 35(3):279-87. PubMed ID: 22842597
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Severe Symptomatic Primary Human Cytomegalovirus Infection despite Effective Innate and Adaptive Immune Responses.
    Riou R; Bressollette-Bodin C; Boutoille D; Gagne K; Rodallec A; Lefebvre M; Raffi F; Senitzer D; Imbert-Marcille BM; Retière C
    J Virol; 2017 Mar; 91(5):. PubMed ID: 28031361
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Reconstitution of cytomegalovirus-specific T-cell response in allogeneic hematopoietic stem cell recipients: the contribution of six frequently recognized, virus-encoded ORFs.
    Nemeckova S; Krystofova J; Babiarova K; Hainz P; Musil J; Sroller V; Maly M; Stastna-Markova M
    Transpl Infect Dis; 2016 Jun; 18(3):381-9. PubMed ID: 27061389
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of serum and CTL on focal growth of human cytomegalovirus.
    Sinzger C; Mangin M; Weinstock C; Topp MS; Hebart H; Einsele H; Jahn G
    J Clin Virol; 2007 Feb; 38(2):112-9. PubMed ID: 17204454
    [TBL] [Abstract][Full Text] [Related]  

  • 76. B-cell-activating factor code and human cytomegalovirus infection in renal transplant recipients.
    Xu H; Dong P; He X; Ma X; Xue D; Zhang Y; Zhang X
    Microbiol Immunol; 2014 Aug; 58(8):439-48. PubMed ID: 24931438
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cytomegalovirus prophylaxis with valganciclovir in cytomegalovirus-seropositive kidney-transplant patients.
    Wéclawiak H; Kamar N; Mengelle C; Guitard J; Esposito L; Lavayssière L; Cointault O; Ribes D; Rostaing L
    J Med Virol; 2008 Jul; 80(7):1228-32. PubMed ID: 18461614
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Monitoring of human cytomegalovirus infection in bone marrow and liver transplant recipients by antigenaemia assay and enzyme-linked immunosorbent assay.
    Zhang X; Fan J; Yang MF; Chen XM; Gao HN; Zhao H; Ma WH; Li LJ
    J Int Med Res; 2009; 37(1):31-6. PubMed ID: 19215671
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Interrelationships among quantity of human cytomegalovirus (HCMV) DNA in blood, donor-recipient serostatus, and administration of methylprednisolone as risk factors for HCMV disease following liver transplantation.
    Cope AV; Sabin C; Burroughs A; Rolles K; Griffiths PD; Emery VC
    J Infect Dis; 1997 Dec; 176(6):1484-90. PubMed ID: 9395358
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Assessing the risk of CMV reactivation and reconstitution of antiviral immune response post bone marrow transplantation by the QuantiFERON-CMV-assay and real time PCR.
    Krawczyk A; Ackermann J; Goitowski B; Trenschel R; Ditschkowski M; Timm J; Ottinger H; Beelen DW; Grüner N; Fiedler M
    J Clin Virol; 2018; 99-100():61-66. PubMed ID: 29331844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.